<DOC>
	<DOCNO>NCT02957136</DOCNO>
	<brief_summary>This randomize clinical trial ass effect rapid , near point-of-care test multiple common respiratory virus bacteria antibiotic anti-influenza medication use emergency department ( ED ) patient symptoms influenza-like illness ( ILI ) and/or upper respiratory infection ( URI ) . The intervention rapid , multi-respiratory pathogen nucleic acid amplification panel test ( FilmArray Respiratory Panel ; BioFire Diagnostics , LLC ) clinical result report within two hour sample collection . Randomization individual patient level . Intervention patient receive usual care plus rapid multi-respiratory pathogen test . Control patient receive physician-directed usual care without rapid , multi-respiratory pathogen test , may include limited testing , point-of-care influenza testing , delay test multiple respiratory pathogen off-site laboratory . The primary outcome antibiotic administration prescription initial ED episode care . The investigator primary hypothesis rapid multi-respiratory pathogen test associate â‰¥15 % reduction antibiotic use intervention patient , relative control patient ( usual care ) . The investigator secondary outcome administration prescription antiviral initial ED episode care . The investigator secondary hypothesis rapid multi-respiratory pathogen test improve anti-influenza medication use intervention patient ( composite rate anti-influenza treatment positive patient non-use anti-influenza treatment negative patient ) , relative control patient receive usual care alone .</brief_summary>
	<brief_title>Rapid Diagnostics Upper Respiratory Infections Emergency Department</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>University California , Davis ( UC Davis ) Emergency Department patient evaluate influenza like illness and/or upper respiratory infection ED physician consent agree nasopharyngeal swab collect study English speak Spanish speaking patient Neonates Prisoners Employees UC Davis/Students Principal Investigator CoPrincipal Investigator NonEnglish , nonSpanish speaking patient</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>101 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Respiratory Tract Infections</keyword>
	<keyword>Influenza , Human</keyword>
	<keyword>Common Cold</keyword>
	<keyword>Viral Infection</keyword>
	<keyword>Pathology , Molecular</keyword>
	<keyword>Molecular Diagnostics</keyword>
	<keyword>Diagnostic Testing</keyword>
	<keyword>Clinical Microbiology</keyword>
	<keyword>Polymerase Chain Reaction</keyword>
	<keyword>Antibiotic Stewardship</keyword>
	<keyword>Antimicrobial Use</keyword>
	<keyword>Emergency Department</keyword>
	<keyword>Emergency Room</keyword>
</DOC>